Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 172
Infectious Diseases Drugs 134
Genomics 106
Liver and Kidney Disorders Drugs 72
Drug Discovery 64
Immune Disorders Drugs 61
Pharmaceuticals 51
Cardiovascular Drugs 50
Biopharmaceuticals 46
Biotechnology 41
Leukemia Drugs 38
HIV/AIDS Drugs 36
Clinical Trials 33
Lymphoma Drugs 30
Respiratory Drugs 29
Musculoskeletal Disorders Drugs 29
Allergy and Immunology 28
Enzymes 26
Pulmonary Medicine 24
Oncology 22
Central Nervous System Drugs 19
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 18
Infectious Disease Testing 14
Vaccines 14
Gastrointestinal Drugs 13
Hematological Drugs 12
Diagnostics 11
Endocrine and Metabolic Disorders Drugs 11
Hematology 10
Sexual and Reproductive Health Drugs 10
Therapeutic Area 9
Healthcare Services 9
Antibiotics 9
Pharmaceutical Intermediates 8
Optical Disorders Drugs 8
Stem Cells 8
Women's Health 7
Breast Cancer Drugs 7
Hepatology 6
Company Reports 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Drugs by Therapeutic Area 3
Generic Drugs 3
Prostate Cancer Drugs 3
Ovarian Cancer Drugs 3
Dental 3
Optical 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Kidney Cancer Drugs 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Brain Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
In Vitro Diagnostics 2
Blood Banking 2
Medical Devices 2
Cancer Vaccines 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Hospital Management 1
Surgical Procedures 1
Molecular Diagnostics 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



278 reviews

1,070 Results (Page 39 of 54)
- Relevance
  Sort by

Antiviral Therapeutics Market - Global Forecast 2025-2030

 Report
August 2025
191 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Direct-acting Antiviral Drug Market - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Aspergillosis Treatment Drug Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Direct Acting Antivirals Market - Global Forecast 2025-2030

 Report
August 2025
193 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Portal Hypertension - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1756EUR$2,000USD£1,527GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Congenital Heart Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1756EUR$2,000USD£1,527GBP

Gene Therapy Market 2024-2028

 Report
June 2024
177 Pages
Global

From

€2195EUR$2,500USD£1,909GBP

Zinc Finger Nuclease Technology Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

 Report
October 2023
190 Pages
Global

From

€3951EUR$4,500USD£3,436GBP

Cytomegalovirus Treatment Market Analysis & Forecast to 2024-2034: Market By Drug Type; By Application; By Distribution Channel; and By Region

 Report
March 2024
200 Pages
Global

From

€3643EUR$4,150USD£3,169GBP

Anti-Rheumatics Market - Global Forecast 2025-2030

 Report
August 2025
192 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Filgotinib Tablets Market - Global Forecast 2025-2030

 Report
August 2025
195 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Oral JAK Inhibitors Market - Global Forecast 2025-2030

 Report
August 2025
195 Pages
Global

From

€3112EUR$3,545USD£2,707GBP

€3458EUR$3,939USD£3,008GBP

Multidrug Resistant Bacteria Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Caspofungin Market

 Report
January 2024
200 Pages
Global

From

€3643EUR$4,150USD£3,169GBP

Pseudomonas Aeruginosa Infection Treatment Market

 Report
January 2024
200 Pages
Global

From

€3643EUR$4,150USD£3,169GBP

Ethical Pharmaceuticals Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Controlled Substance Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

 Report
February 2020
360 Pages
Global

From

€4301EUR$4,899USD£3,741GBP

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

 Report
June 2024
64 Pages
Global

€9757EUR$11,503USD£8,200GBP

Remdesivir Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3942EUR$4,490USD£3,429GBP

1,070 Results (Page 39 of 54)
- 1
- 37
- 38
- 39
- 40
- 41

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.